This page lists the SEC filings reported by ESHELMAN FREDRIC N.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2024-02-21 | ESHELMAN FREDRIC N | G1 Therapeutics, Inc. | 4,216,074 | 8.1% | EDGAR |
| SC 13D/A | 2023-02-13 | ESHELMAN FREDRIC N | EYENOVIA, INC. | 1,708,548 | 4.7% | EDGAR |
| SC 13D/A | 2022-04-05 | ESHELMAN FREDRIC N | Aravive, Inc. | 10,071,985 | 33.9% | EDGAR |
| SC 13D/A | 2022-01-06 | ESHELMAN FREDRIC N | Aravive, Inc. | 4,272,130 | 19.9% | EDGAR |
| SC 13D/A | 2021-02-19 | ESHELMAN FREDRIC N | Aravive, Inc. | 3,806,098 | 19.6% | EDGAR |
| SC 13D/A | 2020-08-28 | ESHELMAN FREDRIC N | EYENOVIA, INC. | 1,691,440 | 6.8% | EDGAR |
| SC 13D/A | 2020-08-14 | ESHELMAN FREDRIC N | EYENOVIA, INC. | 1,691,440 | 8.2% | EDGAR |
| SC 13D | 2020-04-16 | ESHELMAN FREDRIC N | Aravive, Inc. | 931,098 | 5.8% | EDGAR |
| SC 13D/A | 2019-08-20 | ESHELMAN FREDRIC N | EYENOVIA, INC. | 1,674,345 | 9.7% | EDGAR |
| SC 13D | 2018-02-21 | ESHELMAN FREDRIC N | EYENOVIA, INC. | 1,657,515 | 15.0% | EDGAR |
| SC 13D | 2018-02-13 | ESHELMAN FREDRIC N | G1 Therapeutics, Inc. | 3,439,151 | 12.1% | EDGAR |
| SC 13D/A | 2014-04-29 | ESHELMAN FREDRIC N | Furiex Pharmaceuticals, Inc. | 2,979,768 | 27.2% | EDGAR |
| SC 13D/A | 2012-06-29 | ESHELMAN FREDRIC N | Furiex Pharmaceuticals, Inc. | 2,840,856 | 28.6% | EDGAR |
| SC 13D/A | 2012-06-04 | ESHELMAN FREDRIC N | Furiex Pharmaceuticals, Inc. | 2,696,655 | 27.1% | EDGAR |
| SC 13D/A | 2012-05-31 | ESHELMAN FREDRIC N | Furiex Pharmaceuticals, Inc. | 2,576,261 | 25.9% | EDGAR |
| SC 13D/A | 2012-05-25 | ESHELMAN FREDRIC N | Furiex Pharmaceuticals, Inc. | 2,406,055 | 24.2% | EDGAR |
| SC 13D/A | 2012-03-13 | ESHELMAN FREDRIC N | Furiex Pharmaceuticals, Inc. | 2,244,246 | 22.6% | EDGAR |
| SC 13D/A | 2012-02-17 | ESHELMAN FREDRIC N | Furiex Pharmaceuticals, Inc. | 2,086,270 | 21.1% | EDGAR |
| SC 13D/A | 2011-12-15 | ESHELMAN FREDRIC N | Furiex Pharmaceuticals, Inc. | 2,068,911 | 20.9% | EDGAR |
| SC 13D/A | 2011-12-05 | ESHELMAN FREDRIC N | Furiex Pharmaceuticals, Inc. | 1,954,244 | 19.8% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.